Pfizer, Eon Settle Neurontin Patent Claims
Pfizer Inc. agreed Thursday to drop Eon Labs Inc. from a long-running patent infringement suit in New Jersey over a generic version of the epilepsy drug Neurontin....To view the full article, register now.
Already a subscriber? Click here to view full article